Preventing avoidable deaths: Essentials and ......Preventing avoidable deaths: Essentials and...

1
Preventing avo Preventing avo Essentials and recommend Pinto M., Teles S., Carvalho H 1 Agência Piaget para o De Abstract Introdu In spite of a positive European tren recent years, they still account fo intravenous heroin users, exceedin Overdose is the leading cause of death among People who use Drugs (PUD), accounting, in Europe, for more than 3.5% of overall deaths in males under 40 years of age (Eurostat 2012 1 ). intravenous heroin users, exceedin other diseases (UNODC, 2013 2 ). A European countries, overdose dea and is increasing (EMCDDA, 20 additional investments both in co overall deaths in males under 40 years of age (Eurostat 2012 1 ). Heroin/its metabolites are present in the great part of fatal overdoses, and other opioids are also frequently found in toxicological reports. additional investments both in co practices to mitigate this extensive Scope and Objectives This work is inserted in the Euro In the scope of Overdose prevention in Europe – Collating lifesaving practices work package (Euro HRN Project II) the extent of the problem and Harm Reduction (HR) measures to This work is inserted in the Euro Project - Overdose prevention i practices. It is operationalized i following objectives: 1) Facilitate n extent of the problem and Harm Reduction (HR) measures to mitigate drug-related deaths was mapped. A comprehensive literature review on measures to reduce drug-induced deaths was also carried out, and a European group of experts on the regional and national levels; 2) M recommendations on harm redu related deaths, namely drug-induce experts on drug related deaths in was also carried out, and a European group of experts on the topic was created. Based on this, multi-level and cyclical (at different stages of overdose prevention) recommendations for overdose experts on drug related deaths in based opioid overdose manageme meaningful engagement for peo associations around the preven innovative practices for the preve overdose prevention) recommendations for overdose prevention were proposed, addressing Practice, Research and Policy. Gaps the implementation of environmental prevention measures, harm reduction measures aimed at hard-to-reach innovative practices for the preve the improvement of health for peo harm reduction stakeholders from related to work carried out with loc measures, harm reduction measures aimed at hard-to-reach drug users (e.g. HAT, DCR), as well as harm reduction strategies by bystanders (e.g. naloxone) were also identified and addressed. The contents herein presented wor were supported by the activities as In the future, we hope to reunite practitioners, researchers and politics across Europe to form a sustainable critical mass on overdose prevention, dedicated in saving lives. overdose prevention, dedicated in saving lives. Resu Together, the comprehensive literature review, the mapping process and the analyses of the group of experts allowed to identify gaps on overdose prevention at several levels.: - Insufficient development of emergency and hospital staff; - Lack of overdose training ini 1) Establishing a framework for multi-level strategic overdose prevention network; - Liaison issues, mainly between e Research gaps A comprehensive framework was developed in order to support the formulation of recommendations (see Figure 1). This reflects the interrelation of interventions - at multiple environmental levels (from individual to broader) - needed to effectively mitigate the overdose Research gaps - Few research on socioeconomic mortality; major focus on individ - Insufficient effective communica policy; insufficient action-orient individual to broader) - needed to effectively mitigate the overdose problem. 2) Overdose prevention: identifying gaps policy; insufficient action-orient policy making; lack of national r - Few is known (by research) abo on overdose risk/protective fact the drug treatment context; General gaps - Scarce debate on a more suitable and updated conceptual definition of drug-induced deaths; the drug treatment context; - Lack of research investments on protective factors for slow and i definition of drug-induced deaths; - Lack of specific guidelines in the majority of European countries. Practice gaps - Scarce inclusion of environmental strategies (that consider, for Policy gaps - Legislation often hinders or does provision of overdose preven distribution by bystanders; DCR); - Scarce inclusion of environmental strategies (that consider, for example, social inequalities, poverty rates) in overdose intervention programs; - Overdose prevention campaigns are frequently detached from distribution by bystanders; DCR); - Insufficient involvement of PUD making process concerning natio prevention; - Lack of investment on Harm comprehensive interventions and fail to involve PUD and their families; - In some European countries, there is no access to the different substances used in OST ; - Lack of investment on Harm beneficial in the reduction of overd - Some governmental inaction o manufacturers; substances used in OST ; - Deficient training and provision of a daily based individual overdose risk assessment; insufficient assessment of mental health and life events; lack of professionals’ training on overdose management; - Constrained capacity of devel analyses; insufficient registry sy collection and report proceedings comprehensive data on the investig management; comprehensive data on the investig Marta Pinto Contact Financial support for this publication was provided by Co-funding Acknowledgments We would like to acknowledge to the funding entity; Marta Pinto (Project Coordinator) APDES [email protected] Financial support for this publication was provided by Drug Prevention and Information Program of the European Commission. The views expressed herein are those of the authors and in no way reflect the opinions/policies of the donor. We would like to acknowledge to the funding entity; To all the Euro HRN partners; To the WS partner, Heino Stover from Akzept; To the European group of experts on overdose prevention; To EMCDDA, especially to Dagmar Hedrich. To all technicians, researchers and policy makers concerned w issue. issue. To peer educators , committed in saving lives. oidable deaths: oidable deaths: dations on opioid overdose H., Oliveira M.J., Rodrigues C. 1 esenvolvimento (APDES) uction Methods and Materials nd regarding overdose mortality in or almost half of all deaths among ng the ones associated with HIV and The extent of the problem and the HR measures to prevent drug- related deaths was mapped in the 28 EU member states, Norway and Switzerland, based on existing statistics and reports (Akzept ng the ones associated with HIV and Also, in a group of (mostly) north aths continue to be relatively high 014 3 ). Thus, there are necessary ollecting evidences and designing and Switzerland, based on existing statistics and reports (Akzept authorship). Experts meetings were held to discuss strategies for the reduction ollecting evidences and designing issue. opean Harm Reduction Network II Experts meetings were held to discuss strategies for the reduction of drug-induced deaths. A comprehensive literature review on measures to address drug- opean Harm Reduction Network II in Europe Collating lifesaving in work packages that hold the networking at the European, sub- A comprehensive literature review on measures to address drug- related deaths was carried out. Issues concerning drug-induced deaths were analysed in depth. Map good practices and develop uction measures to prevent drug ed deaths; 3) Establish an group of Europe; 4) Advocate for evidence Sources: research papers and reports from EMCDDA, scientific data bases (e.g. Science Direct, MEDLINE, CINAHL, Cochrane), and grey databases (e.g. Google Scholar); publications from multilateral organisms (e.g. EU, WHO, UNODC, UNAIDS, ECDC); Europe; 4) Advocate for evidence ent models and establish models of ople who use drugs and their ntion of overdose; 5) Promote ention of drug related deaths and multilateral organisms (e.g. EU, WHO, UNODC, UNAIDS, ECDC); scientific documents from European and international NG0s (e.g. Beckley Foundation, Harm Reduction International); and position papers from civil society organizations in the harm reduction field, and organizations of people who use drugs. ention of drug related deaths and ople who use drugs; and 6) Support across Europe in sharing practices cal stakeholders. and organizations of people who use drugs. Reviewed: 89 European documents and 67 worldwide. rk as a response to objective 2, and ssociated with objective 3. Recommendations on good policies and practices were based on both 1) literature review and 2) problem’s mapping. ults 3) Recommendations: domains and topics A set of recommendations was designed for each of the domains “opportunistic” interventions by itiatives for PUD’s families/social A set of recommendations was designed for each of the domains and sub-domains explained on Figure 2, concerning Practice, Research and Policy. emergency and drug services. c determinants of drug-related dual/circumstantial factors; cation between research and ted and timely research to benefit ted and timely research to benefit research plans on overdose. out the professionals’ knowledge tors and management, including in n the differentiation of risk and immediate overdose onset. not regulate (legal emptiness) the ntion responses (e.g. naloxone and their families in the decision onal drug strategies for overdose Reduction measures likely to be Reduction measures likely to be doses (e.g. DCR); on the negotiation with naloxone loping toxicological post-mortem ystems’ standardization on data across Europe; scarce collection of gation of deaths . Figure 2: Recommendations on overdose prevention: structure of contents. Conclusions gation of deaths . Conclusions Despite the extent of the problem concerning opioid overdoses in Europe, there is still a lot to do on this field, namely in the collection Europe, there is still a lot to do on this field, namely in the collection of evidences, refinement of practices and the improvement of policies. Several obstacles need to be addressed, beginning with issues on the Several obstacles need to be addressed, beginning with issues on the conceptual definitions, and continuing with the difficulties to accurately estimate the amount of fatal overdoses, due to limitations on mortality registries, poor liaison between services, barriers in the access to treatment, naloxone availability, assessment of mental access to treatment, naloxone availability, assessment of mental health issues, and availability of harm reduction devices likely to be efficacious on mitigating those deaths, among several others. Figure 1: Framework for multi-level strategic overdoses prevention: baseline for literature review and recommendations creation. Inspired in Bronfenbrenner Human Environmental Framework (1979). Concerted efforts among several key actors Practitioners, Researchers, Politicians and PUD/families is absolutely fundamental for the operationalization of the set of existing recommendations aimed at the prevention of deaths that can actually be avoided. aimed at the prevention of deaths that can actually be avoided. 1. Data retrieved from: References 1. Data retrieved from: http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_of_death_statistics#Further_Eurostat_information 2. United Nations Office on Drugs and Crime (UNODC). (2013). Opioid overdose: preventing and reducing opioid overdose mortality. Discussion paper UNODC/WHO 2013. Vienna: UNODC. Retrieved from http://www.unodc.org/docs/treatment/overdose.pdf 3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2014). European drug report 2014: Trends and developments. Luxembourg: Publications Office of the European Union. Retrieved from http://www.emcdda.europa.eu/publications/edr/trends- developments/2014 with the overdose developments/2014

Transcript of Preventing avoidable deaths: Essentials and ......Preventing avoidable deaths: Essentials and...

  • Preventing avoidable deaths:Preventing avoidable deaths:

    Essentials and recommendations on Essentials and recommendations on

    Pinto M., Teles S., Carvalho HPinto M., Teles S., Carvalho H1Agência Piaget para o Desenvolvimento

    Abstract Introduction

    In spite of a positive European trend

    recent years, they still account for

    intravenous heroin users, exceeding

    Overdose is the leading cause of death among People who use

    Drugs (PUD), accounting, in Europe, for more than 3.5% of

    overall deaths in males under 40 years of age (Eurostat 20121).

    Abstract Introduction

    intravenous heroin users, exceeding

    other diseases (UNODC, 20132). Also,

    European countries, overdose deaths

    and is increasing (EMCDDA, 2014

    additional investments both in collecting

    overall deaths in males under 40 years of age (Eurostat 20121).Heroin/its metabolites are present in the great part of fatal

    overdoses, and other opioids are also frequently found in

    toxicological reports.additional investments both in collecting

    practices to mitigate this extensive

    Scope and Objectives

    This work is inserted in the European

    toxicological reports.

    In the scope of Overdose prevention in Europe – Collating

    lifesaving practices work package (Euro HRN Project II) the

    extent of the problem and Harm Reduction (HR) measures to This work is inserted in the EuropeanProject - Overdose prevention in

    practices. It is operationalized in

    following objectives: 1) Facilitate networking

    extent of the problem and Harm Reduction (HR) measures to

    mitigate drug-related deaths was mapped. A comprehensive

    literature review on measures to reduce drug-induced deaths

    was also carried out, and a European group of experts on the following objectives: 1) Facilitate networkingregional and national levels; 2) Map

    recommendations on harm reduction

    related deaths, namely drug-induced

    experts on drug related deaths in

    was also carried out, and a European group of experts on the

    topic was created.

    Based on this, multi-level and cyclical (at different stages of

    overdose prevention) recommendations for overdoseexperts on drug related deaths in

    based opioid overdose management

    meaningful engagement for people

    associations around the prevention

    innovative practices for the prevention

    overdose prevention) recommendations for overdose

    prevention were proposed, addressing Practice, Research and

    Policy. Gaps the implementation of environmental prevention

    measures, harm reduction measures aimed at hard-to-reach innovative practices for the preventionthe improvement of health for people

    harm reduction stakeholders from

    related to work carried out with local

    measures, harm reduction measures aimed at hard-to-reach

    drug users (e.g. HAT, DCR), as well as harm reduction strategies

    by bystanders (e.g. naloxone) were also identified and

    addressed. related to work carried out with localThe contents herein presented work

    were supported by the activities associated

    addressed.

    In the future, we hope to reunite practitioners, researchers and

    politics across Europe to form a sustainable critical mass on

    overdose prevention, dedicated in saving lives.overdose prevention, dedicated in saving lives.

    Results

    Together, the comprehensive literature review, the mapping process

    and the analyses of the group of experts allowed to identify gaps on

    overdose prevention at several levels.:

    - Insufficient development of

    emergency and hospital staff;

    - Lack of overdose training initiatives

    1) Establishing a framework for multi-level strategic overdose

    prevention

    - Lack of overdose training initiatives

    network;

    - Liaison issues, mainly between emergency

    Research gapsA comprehensive framework was developed in order to support the

    formulation of recommendations (see Figure 1). This reflects the

    interrelation of interventions - at multiple environmental levels (from

    individual to broader) - needed to effectively mitigate the overdose

    Research gaps

    - Few research on socioeconomic determinants

    mortality; major focus on individual/circumstantial factors;

    - Insufficient effective communication between research and

    policy; insufficient action-oriented and timely research to benefit individual to broader) - needed to effectively mitigate the overdose

    problem.

    2) Overdose prevention: identifying gaps

    policy; insufficient action-oriented and timely research to benefit

    policy making; lack of national research plans on overdose.

    - Few is known (by research) about the

    on overdose risk/protective factors and management

    the drug treatment context;

    General gaps

    - Scarce debate on a more suitable and updated conceptual

    definition of drug-induced deaths;

    the drug treatment context;

    - Lack of research investments on the differentiation of

    protective factors for slow and immediate

    definition of drug-induced deaths;

    - Lack of specific guidelines in the majority of European countries.

    Practice gaps

    - Scarce inclusion of environmental strategies (that consider, for

    Policy gaps

    - Legislation often hinders or does

    provision of overdose prevention

    distribution by bystanders; DCR);- Scarce inclusion of environmental strategies (that consider, for

    example, social inequalities, poverty rates) in overdose

    intervention programs;

    - Overdose prevention campaigns are frequently detached from

    distribution by bystanders; DCR);

    - Insufficient involvement of PUD

    making process concerning national

    prevention;

    - Lack of investment on Harm- Overdose prevention campaigns are frequently detached from

    comprehensive interventions and fail to involve PUD and their

    families;

    - In some European countries, there is no access to the different

    substances used in OST;

    - Lack of investment on Harm

    beneficial in the reduction of overdoses

    - Some governmental inaction on

    manufacturers;substances used in OST;

    - Deficient training and provision of a daily based individual

    overdose risk assessment; insufficient assessment of mental

    health and life events; lack of professionals’ training on overdose

    management;

    manufacturers;

    - Constrained capacity of developing

    analyses; insufficient registry systems’

    collection and report proceedings

    comprehensive data on the investigationmanagement; comprehensive data on the investigation

    Marta Pinto

    Contact

    Financial support for this publication was provided by

    Co-funding Acknowledgments

    We would like to acknowledge to the funding entity;Marta Pinto

    (Project Coordinator)

    APDES

    [email protected]

    Financial support for this publication was provided by

    Drug Prevention and Information Program of the

    European Commission. The views expressed herein

    are those of the authors and in no way reflect the

    opinions/policies of the donor.

    We would like to acknowledge to the funding entity;

    To all the Euro HRN partners;

    To the WS partner, Heino Stover from Akzept;

    To the European group of experts on overdose prevention;

    To EMCDDA, especially to Dagmar Hedrich.

    To all technicians, researchers and policy makers concerned with

    issue.issue.

    To peer educators , committed in saving lives.

    Preventing avoidable deaths:Preventing avoidable deaths:

    Essentials and recommendations on opioid overdoseEssentials and recommendations on opioid overdose

    H., Oliveira M.J., Rodrigues C.1H., Oliveira M.J., Rodrigues C.

    Desenvolvimento (APDES)

    Introduction Methods and Materials

    trend regarding overdose mortality in

    for almost half of all deaths among

    exceeding the ones associated with HIV and

    Introduction

    • The extent of the problem and the HR measures to prevent drug-related deaths was mapped in the 28 EU member states, Norway

    and Switzerland, based on existing statistics and reports (Akzept

    Methods and Materials

    exceeding the ones associated with HIV and

    Also, in a group of (mostly) north

    deaths continue to be relatively high

    20143). Thus, there are necessary

    collecting evidences and designing

    and Switzerland, based on existing statistics and reports (Akzept

    authorship).

    • Experts meetings were held to discuss strategies for the reductioncollecting evidences and designingissue.

    European Harm Reduction Network II

    • Experts meetings were held to discuss strategies for the reductionof drug-induced deaths.

    • A comprehensive literature review on measures to address drug-European Harm Reduction Network IIin Europe – Collating lifesaving

    in work packages that hold the

    networking at the European, sub-

    • A comprehensive literature review on measures to address drug-related deaths was carried out. Issues concerning drug-induced

    deaths were analysed in depth.

    networking at the European, sub-

    Map good practices and develop

    reduction measures to prevent drug

    induced deaths; 3) Establish an group of

    Europe; 4) Advocate for evidence

    • Sources: research papers and reports from EMCDDA, scientificdata bases (e.g. Science Direct, MEDLINE, CINAHL, Cochrane), and

    grey databases (e.g. Google Scholar); publications from

    multilateral organisms (e.g. EU, WHO, UNODC, UNAIDS, ECDC);Europe; 4) Advocate for evidence

    management models and establish models of

    people who use drugs and their

    prevention of overdose; 5) Promote

    prevention of drug related deaths and

    multilateral organisms (e.g. EU, WHO, UNODC, UNAIDS, ECDC);

    scientific documents from European and international NG0s (e.g.

    Beckley Foundation, Harm Reduction International); and position

    papers from civil society organizations in the harm reduction field,

    and organizations of people who use drugs.prevention of drug related deaths and

    people who use drugs; and 6) Support

    across Europe in sharing practices

    local stakeholders.

    and organizations of people who use drugs.

    • Reviewed: 89 European documents and 67 worldwide.

    local stakeholders.

    work as a response to objective 2, and

    associated with objective 3.

    • Recommendations on good policies and practices were based onboth 1) literature review and 2) problem’s mapping.

    Results

    3) Recommendations: domains and topics

    A set of recommendations was designed for each of the domains

    “opportunistic” interventions by

    initiatives for PUD’s families/social A set of recommendations was designed for each of the domains

    and sub-domains explained on Figure 2, concerning Practice,

    Research and Policy.

    initiatives for PUD’s families/social

    emergency and drug services.

    on socioeconomic determinants of drug-related

    mortality; major focus on individual/circumstantial factors;

    communication between research and

    oriented and timely research to benefit oriented and timely research to benefit

    policy making; lack of national research plans on overdose.

    Few is known (by research) about the professionals’ knowledge

    on overdose risk/protective factors and management, including in

    Lack of research investments on the differentiation of risk and

    and immediate overdose onset.

    not regulate (legal emptiness) the

    prevention responses (e.g. naloxone

    and their families in the decision

    national drug strategies for overdose

    Reduction measures likely to beReduction measures likely to be

    overdoses (e.g. DCR);

    on the negotiation with naloxone

    developing toxicological post-mortem

    systems’ standardization on data

    across Europe; scarce collection of

    investigation of deaths .

    Figure 2: Recommendations on overdose

    prevention: structure of contents.

    Conclusions

    investigation of deaths .

    ConclusionsDespite the extent of the problem concerning opioid overdoses in

    Europe, there is still a lot to do on this field, namely in the collectionEurope, there is still a lot to do on this field, namely in the collection

    of evidences, refinement of practices and the improvement of

    policies.

    Several obstacles need to be addressed, beginning with issues on theSeveral obstacles need to be addressed, beginning with issues on the

    conceptual definitions, and continuing with the difficulties to

    accurately estimate the amount of fatal overdoses, due to limitations

    on mortality registries, poor liaison between services, barriers in the

    access to treatment, naloxone availability, assessment of mentalaccess to treatment, naloxone availability, assessment of mental

    health issues, and availability of harm reduction devices likely to be

    efficacious on mitigating those deaths, among several others.

    Figure 1: Framework for multi-level strategic

    overdoses prevention: baseline for literature

    review and recommendations creation.

    Inspired in Bronfenbrenner Human

    Environmental Framework (1979).

    Concerted efforts among several key actors – Practitioners,

    Researchers, Politicians and PUD/families is absolutely fundamental

    for the operationalization of the set of existing recommendations

    aimed at the prevention of deaths that can actually be avoided.aimed at the prevention of deaths that can actually be avoided.

    1. Data retrieved from:

    References

    1. Data retrieved from:

    http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_of_death_statistics#Further_Eurostat_information

    2. United Nations Office on Drugs and Crime (UNODC). (2013). Opioid overdose: preventing and reducing opioid overdose mortality. Discussion

    paper UNODC/WHO 2013. Vienna: UNODC. Retrieved from http://www.unodc.org/docs/treatment/overdose.pdf

    3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2014). European drug report 2014: Trends and developments.

    Luxembourg: Publications Office of the European Union. Retrieved from http://www.emcdda.europa.eu/publications/edr/trends-

    developments/2014

    with the overdose

    developments/2014